Mesa Laboratories Financials - Benzinga

Mesa Laboratories Inc

MLABNASDAQ

Trade with Public

Trade with Public

$127.15

5.674.67%

At close: Sep 14, 5:00 PM EST

$126.70

5.224.3%

Pre-Market: 4:09 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Dividends Compare Stock Report

Mesa Laboratories Financials

Mesa Laboratories (MLAB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
UPDATE: Mesa Laboratories Q1 Adj. EPS $2.68 Beats $2.40 Estimate, Sales $60.138M Miss $60.867M Estimate

Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $2.40 by 11.67 percent. This is a 15.52 percent increase over earnings of $2.32 per share from

Benzinga Newsdesk

PRO
Mesa Laboratories Q4 Adj. EPS $3.30 Beats $0.34 Estimate, Sales $63.724M Miss $65.171M Estimate

Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $3.30 per share which beat the analyst consensus estimate of $0.34 by 870.59 percent. This is a 46.67 percent increase over earnings of $2.25 per share from

Benzinga Newsdesk

Mesa Laboratories Earnings Review: Q3 Summary

Benzinga Insights

Mesa Laboratories Q3 Earnings Report: What Investors Need to Know

Benzinga Insights

Mesa Laboratories Earnings Report: Q3 Overview

Benzinga Insights

Insights into Mesa Laboratories Q3 Earnings

Benzinga Insights